Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages

Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can activate pro‐inflammatory gene expression in lipopolysaccharide‐stimulated M1‐like macrophages and cannot be blocked by traditional small‐molecule...

Full description

Saved in:

Bibliographic Details
Published in:	Angewandte Chemie International Edition Vol. 62; no. 42; p. e202310059
Main Authors:	Zhao, Chunlong, Chen, Shipeng, Chen, Deng, Río‐Bergé, Clàudia, Zhang, Jianqiu, Van Der Wouden, Petra E., Daemen, Toos, Dekker, Frank J.
Format:	Journal Article
Language:	English
Published:	Weinheim Wiley Subscription Services, Inc 16-10-2023
Edition:	International ed. in English
Subjects:	Anti-inflammatory agents Chimeras Cytokines Gene expression Histone deacetylase Histones Inflammation Lipopolysaccharides Macrophages Molecular modelling Polarization Proteolysis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can activate pro‐inflammatory gene expression in lipopolysaccharide‐stimulated M1‐like macrophages and cannot be blocked by traditional small‐molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase‐independent function of HDAC3. We developed a potent and selective HDAC3‐directed PROTAC, P7 , which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP‐1 cells and human primary macrophages. P7 increases the anti‐inflammatory cytokine secretion in THP‐1‐derived M1‐like macrophages. Importantly, P7 decreases the secretion of pro‐inflammatory cytokines in M1‐like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0‐like into M1‐like macrophage. In conclusion, we demonstrate that the HDAC3‐directed PROTAC P7 has anti‐inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics.
AbstractList	Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase-independent function that can activate pro-inflammatory gene expression in lipopolysaccharide-stimulated M1-like macrophages and cannot be blocked by traditional small-molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase-independent function of HDAC3. We developed a potent and selective HDAC3-directed PROTAC, P7, which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP-1 cells and human primary macrophages. P7 increases the anti-inflammatory cytokine secretion in THP-1-derived M1-like macrophages. Importantly, P7 decreases the secretion of pro-inflammatory cytokines in M1-like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0-like into M1-like macrophage. In conclusion, we demonstrate that the HDAC3-directed PROTAC P7 has anti-inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics.Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase-independent function that can activate pro-inflammatory gene expression in lipopolysaccharide-stimulated M1-like macrophages and cannot be blocked by traditional small-molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase-independent function of HDAC3. We developed a potent and selective HDAC3-directed PROTAC, P7, which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP-1 cells and human primary macrophages. P7 increases the anti-inflammatory cytokine secretion in THP-1-derived M1-like macrophages. Importantly, P7 decreases the secretion of pro-inflammatory cytokines in M1-like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0-like into M1-like macrophage. In conclusion, we demonstrate that the HDAC3-directed PROTAC P7 has anti-inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics. Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can activate pro‐inflammatory gene expression in lipopolysaccharide‐stimulated M1‐like macrophages and cannot be blocked by traditional small‐molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase‐independent function of HDAC3. We developed a potent and selective HDAC3‐directed PROTAC, P7, which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP‐1 cells and human primary macrophages. P7 increases the anti‐inflammatory cytokine secretion in THP‐1‐derived M1‐like macrophages. Importantly, P7 decreases the secretion of pro‐inflammatory cytokines in M1‐like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0‐like into M1‐like macrophage. In conclusion, we demonstrate that the HDAC3‐directed PROTAC P7 has anti‐inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics. Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can activate pro‐inflammatory gene expression in lipopolysaccharide‐stimulated M1‐like macrophages and cannot be blocked by traditional small‐molecule HDAC3 inhibitors. Here we employed the proteolysis targeting chimera (PROTAC) technology to target the deacetylase‐independent function of HDAC3. We developed a potent and selective HDAC3‐directed PROTAC, P7 , which induces nearly complete HDAC3 degradation at low micromolar concentrations in both THP‐1 cells and human primary macrophages. P7 increases the anti‐inflammatory cytokine secretion in THP‐1‐derived M1‐like macrophages. Importantly, P7 decreases the secretion of pro‐inflammatory cytokines in M1‐like macrophages derived from human primary macrophages. This can be explained by the observed inhibition of macrophage polarization from M0‐like into M1‐like macrophage. In conclusion, we demonstrate that the HDAC3‐directed PROTAC P7 has anti‐inflammatory activity and blocks macrophage polarization, demonstrating that this molecular mechanism can be targeted with small molecule therapeutics.
Author	Zhang, Jianqiu Chen, Shipeng Zhao, Chunlong Río‐Bergé, Clàudia Daemen, Toos Van Der Wouden, Petra E. Dekker, Frank J. Chen, Deng
Author_xml	– sequence: 1 givenname: Chunlong orcidid: 0000-0001-7920-8231 surname: Zhao fullname: Zhao, Chunlong organization: Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP) University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 2 givenname: Shipeng surname: Chen fullname: Chen, Shipeng organization: Department of Medical Microbiology and Infection Prevention, Tumor Virology and Cancer Immunotherapy University Medical Center Groningen, University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 3 givenname: Deng orcidid: 0000-0002-6078-6995 surname: Chen fullname: Chen, Deng organization: Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP) University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 4 givenname: Clàudia surname: Río‐Bergé fullname: Río‐Bergé, Clàudia organization: Department of Medical Microbiology and Infection Prevention, Tumor Virology and Cancer Immunotherapy University Medical Center Groningen, University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 5 givenname: Jianqiu surname: Zhang fullname: Zhang, Jianqiu organization: Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP) University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 6 givenname: Petra E. surname: Van Der Wouden fullname: Van Der Wouden, Petra E. organization: Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP) University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 7 givenname: Toos surname: Daemen fullname: Daemen, Toos organization: Department of Medical Microbiology and Infection Prevention, Tumor Virology and Cancer Immunotherapy University Medical Center Groningen, University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands – sequence: 8 givenname: Frank J. orcidid: 0000-0001-7217-9300 surname: Dekker fullname: Dekker, Frank J. organization: Department of Chemical and Pharmaceutical Biology, Groningen, Research Institute of Pharmacy (GRIP) University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands
BookMark	eNpdkctOGzEUhq0KpELotmtLbLqZ1JexZ2YZAiVIRKCKrkcnnjPU4Nip7VRKV30AFn1GngQjLouuzu07v87Rf0j2fPBIyGfOppwx8RW8xalgQpZKdR_IAVeCV7Jp5F7JaymrplX8IzlM6a7wbcv0AXlY2JSLDj1FMJh3DhJS-fj336mNaDIO9Pr71c1snugCfiOd-WzL0PrRwXoNOcQdvQ4ZSxscXe3oiQvm3vrb0nUQ7R_INngaRrpkZc_Ze6TW50CX_K1cgolh8xNuMR2R_RFcwk-vcUJ-fDu7mS-qy6vzi_nssjKiU7nqpBFcSG3qWpmGS9kwNugBJXRd-b-px5UcmhYUH4WooeWDMFoDZ1yNK6FGOSFfXnQ3MfzaYsr92iaDzoHHsE29aFVbM6VlV9Dj_9C7sI2-XFeoptat1loWavpClVdSijj2m2jXEHc9Z_2zOf2zOf27OfIJd2yHXQ
Cites_doi	10.1016/S1525-0016(03)00235-1 10.1002/anie.202004310 10.1128/MCB.21.20.7065-7077.2001 10.1016/j.pharmthera.2017.02.027 10.1016/j.actbio.2016.07.003 10.1073/pnas.1521738113 10.1016/j.intimp.2014.08.002 10.1021/acs.jmedchem.0c00442 10.1016/j.ejmech.2020.112800 10.1016/j.bcp.2016.03.010 10.1021/acs.jmedchem.1c02179 10.1126/science.aas8995 10.1039/D2CS00387B 10.1042/BJ20070779 10.1016/j.critrevonc.2018.05.009 10.1038/s41573-021-00371-6 10.1038/s41419-020-03127-z 10.1056/NEJMra1805035 10.1021/acs.jmedchem.0c00830 10.1101/gad.175950.111 10.1111/bph.15014 10.1038/nrd4360 10.1128/MCB.25.13.5429-5444.2005 10.1016/j.drudis.2013.11.012 10.1002/anie.200501724 10.1073/pnas.1121131109 10.1097/MOL.0000000000000109 10.1038/s41586-020-2576-2 10.1021/jm0303094 10.1002/cbic.202100270 10.1002/cbic.201300201 10.1038/nri1733 10.1016/j.chembiol.2014.12.015 10.1021/acs.jmedchem.2c01159 10.1021/acs.jmedchem.6b01385 10.1038/nrd.2016.211 10.1002/anie.201507978 10.1021/acsptsci.2c00089 10.1016/j.tips.2020.02.006 10.1371/journal.pone.0059702 10.1016/j.chembiol.2021.04.011 10.1039/D0CC03243C 10.1016/j.drudis.2016.08.006 10.1002/med.21505 10.1021/acs.jmedchem.8b00136 10.1039/D2CS00148A 10.1021/acschembio.5b00640
ContentType	Journal Article
Copyright	2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Copyright_xml	– notice: 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
DBID	AAYXX CITATION 7TM K9. 7X8
DOI	10.1002/anie.202310059
DatabaseName	CrossRef Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic
DatabaseTitle	CrossRef ProQuest Health & Medical Complete (Alumni) Nucleic Acids Abstracts MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) CrossRef
DeliveryMethod	fulltext_linktorsrc
Discipline	Chemistry
EISSN	1521-3773
Edition	International ed. in English
ExternalDocumentID	10_1002_anie_202310059
GroupedDBID	--- -DZ -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 23M 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 6TJ 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAMNL AANLZ AAONW AAXRX AAYXX AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABPPZ ABPVW ACAHQ ACCFJ ACCZN ACFBH ACGFS ACIWK ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB B-7 BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BTSUX BY8 CITATION CS3 D-E D-F D0L DCZOG DPXWK DR1 DR2 DRFUL DRSTM EBS F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES M53 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PQQKQ Q.N Q11 QB0 QRW R.K RNS ROL RWI RX1 RYL SUPJJ TN5 UB1 UPT UQL V2E VQA W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WXSBR WYISQ XG1 XPP XSW XV2 YZZ ZZTAW ~IA ~KM ~WT 7TM K9. 7X8
ID	FETCH-LOGICAL-c295t-93c21236c445c7133700d6de3a9920274fb3d78a51f224a81d2c66a1015fb25f3
ISSN	1433-7851 1521-3773
IngestDate	Sat Oct 26 04:10:54 EDT 2024 Tue Nov 19 06:27:58 EST 2024 Thu Nov 21 22:31:58 EST 2024
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	42
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c295t-93c21236c445c7133700d6de3a9920274fb3d78a51f224a81d2c66a1015fb25f3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ORCID	0000-0001-7217-9300 0000-0001-7920-8231 0000-0002-6078-6995
OpenAccessLink	https://doi.org/10.1002/anie.202310059
PQID	2874686663
PQPubID	946352
ParticipantIDs	proquest_miscellaneous_2858405639 proquest_journals_2874686663 crossref_primary_10_1002_anie_202310059
PublicationCentury	2000
PublicationDate	2023-10-16
PublicationDateYYYYMMDD	2023-10-16
PublicationDate_xml	– month: 10 year: 2023 text: 2023-10-16 day: 16
PublicationDecade	2020
PublicationPlace	Weinheim
PublicationPlace_xml	– name: Weinheim
PublicationTitle	Angewandte Chemie International Edition
PublicationYear	2023
Publisher	Wiley Subscription Services, Inc
Publisher_xml	– name: Wiley Subscription Services, Inc
References	e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_1_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1
References_xml	– ident: e_1_2_7_13_1 doi: 10.1016/S1525-0016(03)00235-1 – ident: e_1_2_7_26_1 doi: 10.1002/anie.202004310 – ident: e_1_2_7_15_1 doi: 10.1128/MCB.21.20.7065-7077.2001 – ident: e_1_2_7_31_1 doi: 10.1016/j.pharmthera.2017.02.027 – ident: e_1_2_7_1_1 doi: 10.1016/j.actbio.2016.07.003 – ident: e_1_2_7_38_1 doi: 10.1073/pnas.1521738113 – ident: e_1_2_7_39_1 doi: 10.1016/j.intimp.2014.08.002 – ident: e_1_2_7_45_1 doi: 10.1021/acs.jmedchem.0c00442 – ident: e_1_2_7_32_1 doi: 10.1016/j.ejmech.2020.112800 – ident: e_1_2_7_20_1 doi: 10.1016/j.bcp.2016.03.010 – ident: e_1_2_7_47_1 doi: 10.1021/acs.jmedchem.1c02179 – ident: e_1_2_7_11_1 doi: 10.1126/science.aas8995 – ident: e_1_2_7_34_1 doi: 10.1039/D2CS00387B – ident: e_1_2_7_18_1 doi: 10.1042/BJ20070779 – ident: e_1_2_7_6_1 doi: 10.1016/j.critrevonc.2018.05.009 – ident: e_1_2_7_23_1 doi: 10.1038/s41573-021-00371-6 – ident: e_1_2_7_2_1 doi: 10.1038/s41419-020-03127-z – ident: e_1_2_7_8_1 doi: 10.1056/NEJMra1805035 – ident: e_1_2_7_9_1 doi: 10.1021/acs.jmedchem.0c00830 – ident: e_1_2_7_21_1 doi: 10.1101/gad.175950.111 – ident: e_1_2_7_40_1 doi: 10.1111/bph.15014 – ident: e_1_2_7_7_1 doi: 10.1038/nrd4360 – ident: e_1_2_7_16_1 doi: 10.1128/MCB.25.13.5429-5444.2005 – ident: e_1_2_7_12_1 doi: 10.1016/j.drudis.2013.11.012 – ident: e_1_2_7_25_1 doi: 10.1002/anie.200501724 – ident: e_1_2_7_19_1 doi: 10.1073/pnas.1121131109 – ident: e_1_2_7_3_1 doi: 10.1097/MOL.0000000000000109 – ident: e_1_2_7_10_1 doi: 10.1038/s41586-020-2576-2 – ident: e_1_2_7_36_1 doi: 10.1021/jm0303094 – ident: e_1_2_7_30_1 doi: 10.1002/cbic.202100270 – ident: e_1_2_7_14_1 doi: 10.1002/cbic.201300201 – ident: e_1_2_7_5_1 doi: 10.1038/nri1733 – ident: e_1_2_7_42_1 doi: 10.1016/j.chembiol.2014.12.015 – ident: e_1_2_7_27_1 doi: 10.1021/acs.jmedchem.2c01159 – ident: e_1_2_7_44_1 doi: 10.1021/acs.jmedchem.6b01385 – ident: e_1_2_7_24_1 doi: 10.1038/nrd.2016.211 – ident: e_1_2_7_22_1 doi: 10.1002/anie.201507978 – ident: e_1_2_7_28_1 doi: 10.1021/acsptsci.2c00089 – ident: e_1_2_7_41_1 doi: 10.1016/j.tips.2020.02.006 – ident: e_1_2_7_17_1 doi: 10.1371/journal.pone.0059702 – ident: e_1_2_7_29_1 doi: 10.1016/j.chembiol.2021.04.011 – ident: e_1_2_7_46_1 doi: 10.1039/D0CC03243C – ident: e_1_2_7_4_1 doi: 10.1016/j.drudis.2016.08.006 – ident: e_1_2_7_37_1 doi: 10.1002/med.21505 – ident: e_1_2_7_43_1 doi: 10.1021/acs.jmedchem.8b00136 – ident: e_1_2_7_33_1 doi: 10.1039/D2CS00148A – ident: e_1_2_7_35_1 doi: 10.1021/acschembio.5b00640
SSID	ssj0028806
Score	2.4875565
Snippet	Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase‐independent function that can... Macrophage polarization plays a crucial role in inflammatory processes. The histone deacetylase 3 (HDAC3) has a deacetylase-independent function that can...
SourceID	proquest crossref
SourceType	Aggregation Database
StartPage	e202310059
SubjectTerms	Anti-inflammatory agents Chimeras Cytokines Gene expression Histone deacetylase Histones Inflammation Lipopolysaccharides Macrophages Molecular modelling Polarization Proteolysis
Title	Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages
URI	https://www.proquest.com/docview/2874686663 https://www.proquest.com/docview/2858405639
Volume	62
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Pb9MwFLe6cYAL4q8oDGQkJA5VILGdODl2bace1q3aOmniEiWxs1aUdKKN0DjxATjwGfkkvBcnbgoSGgcuUeokluv3y3s_vzy_R8gbLULlAU918iBUjkiEciI3D5yMMamkTqWuMvCNz-XJZTgciVGn05RQ3bb9V0lDG8gad87-g7Rtp9AA5yBzOILU4XgruVd5PwqMBkoyvbkBcqx73IY0GA0HJHN6djrrD9a9MVYf6hebhb0FBgEo-WS-vk9XGwwnAjkCTT0Ew4eedQyagyX2V8s2J659ern4iGlIgNFOvN3GSYLVwuagv9ZtRtwvrvSXBDcV9KrkBfo3J-VILdqxAh_miXHuzstiuarNbhWeYPTn-XxxrbfNQ210GV62ty6r6AC3hFejd1adD1d2rIcY71ZFD7QdIqwKrTP7NW-pdlvqXnDuyLBOeatrE8A8ULumwEpjIwLWehdMOrA_bI_JZYuJAd7hsDzc17u1sk1kwclpfHRxfBzPRpezPXKHgX5E9cz51PoJQKWaTXH14Jpcoy57v9v7LpfapRIVP5o9IPfrhQ3tG0Q-JB1dPCJ3B009wcfke41M2kIm5T-__WgwSWtMUsQkRUzCxTYaqUUjTW9og0baRiNd5XTiwnMIOYo4pBOv-dlC4BNycTSaDcZOXQsEtEbkb5yIZ0iygkwIP0PHinRdFSjNkyhC_53IU65kmPheDqQ0gVUYy4IgAYPj5ynzc_6U7BfwH58RCktkoTwpZcZ9ISMZqjxKec5EypTQOuuSt82sxtcm5UtsknuzGOc_tvPfJQfNpMe1CljHWEAiCANg8l3y2l6GucYvcUmhVyXeA7wflh48ev73Ll6Qe1uIH5D9zedSvyR7a1W-qjDzC9V2ssA
link.rule.ids	315,782,786,27933,27934
linkProvider	Wiley-Blackwell
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Histone+Deacetylase+3%E2%80%90Directed+PROTACs+Have+Anti%E2%80%90inflammatory+Potential+by+Blocking+Polarization+of+M0%E2%80%90like+into+M1%E2%80%90like+Macrophages&rft.jtitle=Angewandte+Chemie+International+Edition&rft.au=Zhao%2C+Chunlong&rft.au=Chen%2C+Shipeng&rft.au=Deng%2C+Chen&rft.au=Cl%C3%A0udia+R%C3%ADo%E2%80%90Berg%C3%A9&rft.date=2023-10-16&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1433-7851&rft.eissn=1521-3773&rft.volume=62&rft.issue=42&rft_id=info:doi/10.1002%2Fanie.202310059&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1433-7851&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1433-7851&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1433-7851&client=summon